Imaging Technology News: First FLASH proton therapy trial completed in humans
The Cincinnati Children’s Hospital Medical Center/UC Health Proton Therapy Center recently completed enrollment in the first human trial of FLASH therapy, called FAST-01, in October.
John C. Breneman, MD, professor emeritus in the Department of Radiation Oncology in the University of Cincinnati's College of Medicine, medical director of the Cincinnati Children's Hospital Medical Center/UC Health Proton Therapy Center and a University of Cincinnati Cancer Center member, recently spoke with Imaging Technology News (ITN) about FLASH therapy and the FAST-01 trial.
"The way that FLASH radiotherapy differs from conventional radiotherapy isn’t necessarily that it’s a different kind of radiation, it’s different because of how quickly it’s given," Breneman told ITN. "Most radiation therapy is given in treatments that may last two, three, four, five minutes. FLASH radiotherapy gives actually somewhat larger doses than what we conventionally use in day to day treatments and delivers them in just a fraction of a second, and it’s that very fast delivery of the radiation dose that seems to have the effect of being able to spare the normal tissue while still being able to kill and treat tumor tissue."
The FAST-01 trial enrolled 10 patients with bone metastases in their arms and legs, and Breneman and his team are currently conducting follow-up studies to examine potential side effects and the treatment's effectiveness to treat the cancer.
Featured photo at top of Cincinnati Children’s/UC Health Proton Therapy Center's proton treatment room courtesy of Cincinnati Children's/UC Health.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.